Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation Company to...
Read: Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by UMDFWhite House Releases Fiscal Year (FY) 2023 Budget Request – Big Proposed Increases for Research On Monday, March 28, 2022, President...
Read: Advocacy Update – April 2022TK2d Patient Listening Session – Monday, January 31, 2022 Click here for the downloadable PDF of this report. WHAT IS A PATIENT...
Read: TK2d Patient Listening Session – January 2022Omnibus Bill Includes 151-Day Extension of Telehealth Waivers Earlier this week, President Biden signed a bill to fund the government through...
Read: Advocacy Update – March 2022United Mitochondrial Disease Foundation 2022 Congressional Outlook As it reconvenes, Congress faces a packed agenda in a legislative year that...
Read: UMDF’s 2022 Congressional OutlookLeigh Syndrome International Consortium Awards Second Round of Research Grants The Leigh Syndrome International Consortium, a patient-driven...
Read: LSIC Awards Second Round of Research GrantsUMDF Elevates TK2d Patient Voices at FDA Pittsburgh, PA (January 31, 2021) – The United Mitochondrial Disease Foundation (UMDF) –...
Read: UMDF Elevates TK2d Patient Voices at FDAUMDF Launches WCG CenterWatch iConnect Clinical Trial Finder Tool Specific to Mitochondrial Disease Pittsburgh, PA (December 15, 2021)...
Read: UMDF Launches WCG CenterWatch iConnect Clinical Trial Finder Tool(Pittsburgh, PA) The United Mitochondrial Disease Foundation (UMDF) has announced the appointment of Alan Breslow of Cherry Hill, NJ, to its...
Read: Alan Breslow Appointed to UMDF Board of TrusteesEach year, thousands of donors contribute to our mission of support, education, research, and advocacy. In the interest of transparency, UMDF...
Read: UMDF Financial Statements